Artemis Medicare Services: The financial results for the period ended September 30, 2026
Artemis Medicare Services (ARTEMISMED) filed a disclosure titled "The financial results for the period ended September 30, 2026". The company is valued at about ₹4,717 crore.
What happened
Artemis Medicare Services (ARTEMISMED) filed a disclosure with the exchanges on 30 October 2026 at 05:45 PM titled "The financial results for the period ended September 30, 2026".
Company snapshot
Artemis Medicare Services is a small-cap company, with a market value of about ₹4,717 crore.
The stock last traded at ₹298, against a 52-week range of ₹203.4–₹378.8 (21.3% below the high).
Before this filing the shares had moved −18.6% over the month and −0.2% over three months. Average daily turnover over the last 20 sessions was about ₹9.11 crore.
Promoters held 58.39% at the end of Q1 FY27; 44.53% of promoter shares were pledged. Foreign institutions owned 12.29% and domestic institutions 2.40%.
| Quarter | Revenue | Net profit | EPS (₹) |
|---|---|---|---|
| Q1 FY26 | 255 | 21.3 | 1.35 |
| Q2 FY26 | 275 | 30 | 1.9 |
| Q3 FY26 | 272 | 22.3 | 1.41 |
| Q4 FY26 | 279 | 30 | 1.9 |
| Q1 FY27 | 287 | 31.3 | 1.98 |
What history shows
This is not the company's first results disclosure: BCEIE has 1 earlier filing of this kind on record since May 2026.
Market-wide, 10,043 results filings with an impact score of 50 or more saw an average next-day move of −0.3%, with 42% rising.
Past reactions describe what happened before; they are not a forecast.
What to watch
- Management commentary, margins and order book or guidance in the investor presentation.
- 30 October 2026: Board meeting — Financial Results.
In the news
Recent coverage elsewhere (links open the original publisher):
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.